These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11082418)

  • 1. P2 purinergic receptors: modulation of cell function and therapeutic potential.
    Burnstock G; Williams M
    J Pharmacol Exp Ther; 2000 Dec; 295(3):862-9. PubMed ID: 11082418
    [No Abstract]   [Full Text] [Related]  

  • 2. Developments in P2 receptor targeted therapeutics.
    Williams M
    Prog Brain Res; 1999; 120():93-106. PubMed ID: 10550990
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for two different types of P2 receptors stimulating insulin secretion from pancreatic B cell.
    Petit P; Hillaire-Buys D; Manteghetti M; Debrus S; Chapal J; Loubatières-Mariani MM
    Br J Pharmacol; 1998 Nov; 125(6):1368-74. PubMed ID: 9863669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2 purinergic signalling in the pancreatic beta-cell: control of insulin secretion and pharmacology.
    Petit P; Lajoix AD; Gross R
    Eur J Pharm Sci; 2009 May; 37(2):67-75. PubMed ID: 19429412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The functions of ATP receptors in the synaptic transmission in the hippocampus.
    Inoue K; Koizumi S; Ueno S; Kita A; Tsuda M
    Prog Brain Res; 1999; 120():193-206. PubMed ID: 10550998
    [No Abstract]   [Full Text] [Related]  

  • 6. Extracellular adenosine 5'-triphosphate modulates insulin secretion via functionally active purinergic receptors of X and Y subtype.
    Santini E; Cuccato S; Madec S; Chimenti D; Ferrannini E; Solini A
    Endocrinology; 2009 Jun; 150(6):2596-602. PubMed ID: 19196799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP as a death factor.
    Di Virgilio F
    Biofactors; 1998; 8(3-4):301-3. PubMed ID: 9914832
    [No Abstract]   [Full Text] [Related]  

  • 8. Adenosine triphosphate release and purinergic regulation of cholangiocyte transport.
    Feranchak AP; Fitz JG
    Semin Liver Dis; 2002 Aug; 22(3):251-62. PubMed ID: 12360419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual effect of ATP on glucose-induced insulin secretion in HIT-T15 cells.
    Lee DH; Park KS; Kim DR; Lee JW; Kong ID
    Pancreas; 2008 Oct; 37(3):302-8. PubMed ID: 18815553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP-induced apoptosis of thymocytes is mediated by activation of P2 X 7 receptor and involves de novo ceramide synthesis and mitochondria.
    Lépine S; Le Stunff H; Lakatos B; Sulpice JC; Giraud F
    Biochim Biophys Acta; 2006 Jan; 1761(1):73-82. PubMed ID: 16325464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP as an osteoclast regulator?
    Arnett TR; King BF
    J Physiol; 1997 Sep; 503 ( Pt 2)(Pt 2):236. PubMed ID: 9306268
    [No Abstract]   [Full Text] [Related]  

  • 12. Water induces autocrine stimulation of tumor cell killing through ATP release and P2 receptor binding.
    Selzner N; Selzner M; Graf R; Ungethuem U; Fitz JG; Clavien PA
    Cell Death Differ; 2004 Dec; 11 Suppl 2():S172-80. PubMed ID: 15459753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2Y receptor mediated modulation of insulin release by a novel generation of 2-substituted-5'-O-(1-boranotriphosphate)-adenosine analogues.
    Farret A; Filhol R; Linck N; Manteghetti M; Vignon J; Gross R; Petit P
    Pharm Res; 2006 Nov; 23(11):2665-71. PubMed ID: 17048117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of P2X receptors: distribution and pathophysiological roles.
    Burnstock G
    Proc West Pharmacol Soc; 1999; 42():119-21. PubMed ID: 10697712
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of dopamine-mediated facilitation at the neuromuscular junction of Wistar rats: A role for adenosine A1/A2A receptors and P2 purinoceptors.
    Elnozahi NA; AlQot HE; Mohy El-Din MM; Bistawroos AE; Abou Zeit-Har MS
    Neuroscience; 2016 Jun; 326():45-55. PubMed ID: 27060487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2 receptors in bone--modulation of osteoclast formation and activity via P2X7 activation.
    Gartland A; Buckley KA; Hipskind RA; Bowler WB; Gallagher JA
    Crit Rev Eukaryot Gene Expr; 2003; 13(2-4):237-42. PubMed ID: 14696970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and function of P2 purinocepters.
    Weisman GA; Turner JT; Fedan JS
    J Pharmacol Exp Ther; 1996 Apr; 277(1):1-9. PubMed ID: 8613904
    [No Abstract]   [Full Text] [Related]  

  • 18. Extracellular adenosine triphosphate. A shock to hemopoietic cells.
    Nijweide PJ; Modderman WE; Hagenaars CE
    Clin Orthop Relat Res; 1995 Apr; (313):92-102. PubMed ID: 7641503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional evidence that ATP or a related purine is an inhibitory NANC neurotransmitter in the mouse jejunum: study on the identity of P2X and P2Y purinoceptors involved.
    De Man JG; De Winter BY; Seerden TC; De Schepper HU; Herman AG; Pelckmans PA
    Br J Pharmacol; 2003 Nov; 140(6):1108-16. PubMed ID: 14530212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer.
    Shabbir M; Ryten M; Thompson C; Mikhailidis D; Burnstock G
    BJU Int; 2008 Feb; 101(3):352-9. PubMed ID: 18005209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.